


The Fund aims to achieve above average capital growth.
| Name | % Net Assets |
|---|---|
| HSBC Holdings PLC | 6.6% |
| BNP Paribas S.A | 5.2% |
| HARGREAVES LANSDOWN PLC | 4.9% |
| FRESENIUS MEDICAL CARE AG & CO.KGAA | 4.5% |
| BASF SE | 4.4% |
| BG Group PLC | 4.1% |
| Qiagen N.V. | 4.0% |
| Bayer AG | 4.0% |
| Etablissementen Franz Colruyt N.V. | 4.0% |
| Vodafone Group PLC | 3.9% |
| Key | % Net Assets |
|---|---|
| 6.6% | |
| 5.2% | |
| 4.9% | |
| 4.5% | |
| 78.8% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 540.53p |
| Currency | GBP |
| Change | -0.38p |
| % | -0.07% |
| YTD change | 52.33p |
| YTD % | 10.72% |
| Fund Inception | 12/07/2004 |
|---|---|
| Fund Manager | Dan Ison |
| TER | 1.67 (30-Mar-2012) |
| Minimum Investment | |
|---|---|
| Initial | £5000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 3.75% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.09 |
You are here: research